Integrative Medicine International
Conflicts of Interest
Multimedia Files and Supplementary Material
English Language Editing
Article Processing Charge (APC)
Self-Archiving, Funding Organizations (NIH, etc)
Digital Object Identifier (DOI)
Before submission, please read these Guidelines for Authors for specific requirements for manuscript preparation.
Presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org) from the International Committee of Medical Journal Editors.
'Integrative Medicine International' is a peer-reviewed open access journal that serves as an instant media platform for those wishing to publish research reports and any other relevant content dealing with diagnosis, evaluation and therapy. The journal focuses on the latest trends and developments, experiences and achievements in all areas of integrative medicine, complementary and alternative medicine (CAM), as well as advances in the attempt to modernize traditional medicine. This includes traditional herbal medicine, acupuncture, tai chi, chiropractic, massage, mind-body therapy (music therapy), yoga therapy, Ayurveda, creative therapy, nutrition counseling and exercise programs. Manuscripts can be submitted in the form of original articles, review articles, herb-drug interaction reports, clinical trials and clinical experiences. The objective of the journal is to publish new methods in research and therapy to complement and extend the methods of western medicine. Due to its integrative and cross-disciplinary approach, the journal should be of interest to readers worldwide.
Manuscripts written in English are considered and should be submitted online.
Decisions on manuscripts will be made in less than 3 weeks.
Names, postal and e-mail addresses of 2-3 international experts in the appropriate area of research should accompany each manuscript. At the Editors' discretion, scientist(s) selected from this list may be invited to act as referee(s). Referees suggested should not be from the same institution as the author, nor have collaborated with any of the authors within the last 3 years.
Submission of an article implies author agreement with the below Conditions. To be considered for publication, all manuscripts must be accompanied by a cover letter signed by all authors stating that the work has not been published, nor is under consideration elsewhere, and that all authors approve the submission.
In case of problems with submission, please contact:
Editorial Office 'Integrative Medicine International'
S. Karger AG
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1424
Fax +41 61 306 1434
All manuscripts are subject to editorial and peer-review. Manuscripts are received with the explicit understanding that the work has not been published (wholly nor in part), and is not under simultaneous consideration in any language elsewhere. Furthermore, all authors have made substantial contributions and confirm that they have seen and approve the manuscript submission.
Copyright of manuscripts is retained by the authors. Authors grant S. Karger AG, Basel, an exclusive unlimited license to publish the article under a Creative Commons license and identify S. Karger AG as the original publisher. Submission of an article for publication implies the authors’ consent to publication under the applicable Creative Commons license and the terms and conditions of the Publisher’s Licensing Agreement.. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.
All articles in this journal are Open Access and meet the requirements of funding bodies or academic institutions. Articles are licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license (CC BY-NC-ND). Articles can be read, downloaded, printed, and shared provided that use is for non-commercial purposes only, no modifications or adaptations are made, and proper credit is given to the authors as well as the original publisher. For research funded by the Wellcome Trust, Research Councils UK (RCUK) and other organizations with the same requirements, papers are published under the Creative Commons Attribution 4.0 International license (CC BY 4.0).
Please contact Karger's Open Access team at firstname.lastname@example.org with questions regarding your funding body or other matters.
'Integrative Medicine International' is a peer-reviewed journal that uses a single-blind peer-review. Our aim is to provide authors with fast and constructive feedback regarding their submitted manuscript. The Editor-in-Chief and the international editorial board ensure a thorough and fair peer-review and the highest scientific publishing standards. Editors guide the peer-review process for papers in their areas of expertise. They select reviewers and make the decision whether to accept/reject or send a manuscript for revision after at least two review reports are received, and then a further decision to accept/reject or request further revisions following author revisions. Reviewers must have a recent publication record in the area of the submission, must not have published with the authors in the previous three years, and must not be from the same institution as the authors. The Editor-in-Chief is responsible to maintain high-quality peer-review of papers submitted to the journal.
Conflicts of Interest
Authors are required to disclose any sponsorship or funding arrangements related to the research presented in the manuscript and any possible conflicts of interest. A possible conflict of interest does not preclude consideration of a manuscript for publication, but Conflict of Interest statements will be published at the end of the article. All forms of support and financial involvement should be listed in the Acknowledgements section of the paper. The cover letter should certify that all forms of conflict of interest by all authors were clearly identified in the text.
Research must comply with the guidelines for human studies and animal welfare regulations. Manuscripts reporting studies on human subjects should include evidence that the research was ethically conducted in accordance with the World Medical Association Declaration of Helsinki. In particular, authors must state in the Materials and Methods section that subjects (or their parents or guardians) have given their informed written consent and that the study protocol was approved by an appropriate ethics committee. All patients should be identified by numbers or aliases, not by their real names. Authors should also state that animal experimentation was approved by the appropriate institutional review body. Copies of these guidelines and policy statements must be available for review by the editors if necessary.
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).
Authors should indicate in the cover letter which manuscript type is being submitted for publication:
Original Papers: Fully documented reports of original research that must describe full sets of interesting, original experiments in current research. An Abstract (see below), Introduction, Materials and Methods, Results, and Discussion sections are required. Consideration for publication is based on originality, novelty, scientific soundness, and appropriate analysis. (Maximum 2,500 words, 80 references, plus tables/figures).
In-Depth Topic Reviews: Comprehensive, state-of-the-art papers covering a timely topic by experts in the field. Reviews are usually invited by the Editor but may be unsolicited. Authors are asked to contact the Editor-in-Chief before submission in order to avoid clashes with other pending reviews. All reviews are subject to peer-review. An abstract of no more than 250 words is required. (Maximum 4,000 words, plus tables/figures, references)
The preferred word processing program is MS-Word. The cover letter, the manuscript, the tables and figures must be submitted in separate files. The manuscript file must contain all the text elements in the following order: title page, abstract and key words, main text, acknowledgments, references, table and figure legends. Tables and figures should be submitted as separate files according to the instructions below. Automatic line numbering should be used, continuous from the title page through to the final page. All pages should be numbered, starting from the title page, including figure legends, tables and figures.
Title page: The first page should contain a concise title of the article along with a short title for use as a running head (no more than 80 characters), the full names of the authors and their affiliations (hospital, institute etc. where the work was conducted). The full postal address, telephone and fax numbers, as well as the e-mail address of the author to whom correspondence should be sent must be given at the bottom of the title page.
Key words: 3–10 key words that reflect the content of the paper must be included.
Abstracts of Original Reports: Each Original Report needs an abstract of up to 250 words, structured with subheadings as follows:
Background/Aims: What is the major problem that prompted the study?
Methods: How was the study performed?
Results: Most important findings?
Conclusion: Most important conclusion?
Abstracts of In-Depth Topic Reviews: Should be divided into the following subsections:
Background: A brief clinical context for the review.
Summary: Should include a concise description of the main topics covered in the text.
Key Messages: The main conclusions of the review.
Footnotes: Footnotes should be avoided. When essential, they should be numbered consecutively and appear at the foot of the appropriate page.
Acknowledgements: Include all sources of funding for the research presented in the manuscript, and substantive contributions of individuals regarding the research or manuscript.
Abbreviations: Abbreviations (with the exception of those clearly well-established in the field) should be explained when they are first used
Units of measurement: Measurements should be expressed in SI units wherever possible.
Drug names: Use generic names of drugs (first letter: lowercase) whenever possible. Registered trade names (first letter: uppercase) should be marked with the superscript registration symbol ® or ™ when they are first mentioned.
Tables and illustrations: Tables and figures must be numbered (e.g. Figure 1, Figure 2) and submitted as separate files. Tables require a heading and figures a legend, which must provide sufficient information for either to stand alone. Each figure and table must be cited in the text numerically. Tables should be in Word format. B/w half-tone and color figures must have a final resolution of 300 dpi after scaling to final size, line drawings 1200 dpi. Color figures must be in RGB format. All figures should be in a common format such as PSD, TIF, PNG, EPS or WMF. Vector graphics should be in PPT, AI or EPS format. See the Technical Instructions for more information.
Color illustrations are reproduced free of charge.
Identify references in the text using Arabic numerals [in square brackets]. Do not alphabetize; number references sequentially in the order cited in the text. Material submitted for publication but not yet accepted should be referred to as ‘unpublished data’ and should not be included in the reference list. The reference list should include only those publications which are cited in the text. Each Author's surname should be followed by their initials with no punctuation other than a comma to separate individual authors. Preferably cite all authors (if not possible include at least 3 authors followed by et al). Abbreviate journal names according to the list of journals indexed for MEDLINE on the NLM website. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).
(a) Papers published in periodicals:
Nopp A, Cardell LO, Johansson SGO: CD-Sens can be a reliable and easy-to-use complement in the diagnosis of allergic rhinitis. Int Arch Allergy Immunol 2013;161:8790.
(b) Papers published only with DOI numbers:
Rubin DA, Cano-Sokoloff N, Castner DL, Judelson DA, Wright P, Duran A, Haqq AM: Update on body composition and bone density in children with Prader-Willi syndrome. Horm Res Paediatr DOI: 10.1159/000350824.
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 4, revised. Basel, Karger, 2007.
(d) Edited books:
Costa-Pinto FA, Basso AS: Neural and behavioral correlates of food allergy; in Bienenstock J (ed): Allergy and the Nervous System. Chem Immunol Allergy. Basel, Karger, 2012, vol 98, pp 222239.
Karger Publishers: Transforming Vesalius: The 16th-Century Scientific Revolution Brought to Life for the 21st Century. Basel, Karger, 2013. http://www.vesaliusfabrica.com/en/new-fabrica.html.
(f) Websites with access date:
World Health Organization: Leprosy elimination project: status report. 2003. http://www.who.int/lep/Reports/s20042.pdf (accessed May 15, 2005).
Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Supplementary material will be hosted online at https://karger.figshare.com. Authors will be charged a processing fee of CHF 250.00 for supplementary material.
English Language Editing
For authors whose native language is not English, use of a professional language editing service prior to submission can help to avoid delays with the review process.
Article Processing Charge (APC)
For the moment there is no Article Processing Charge (APC).
Karger permits authors of Open Access articles to post the final, published version of their articles in Open Access repositories or on other websites, in accordance with the relevant Creative Commons license. Re-posted Open Access articles must:
- Follow the terms of the relevant Creative Commons license
- Be linked to the final version on www.karger.com
- Include the following statement:
It is the author’s responsibility to fulfill these requirements.
Articles to be archived in PubMed Central for any reason, including funding requirements, must be submitted by Karger (see below):
Funding Organizations (NIH, etc)
The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits the final, published version of Open Access NIH-funded articles to PubMed Central (PMC) immediately upon publication. The paper usually receives a PMCID within approximately a month. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC. Authors should include information on their grant in the Acknowledgements section of their papers.
Manuscripts to be archived in PMC due to funding requirements will be submitted by Karger on the author’s behalf.
Manuscripts accepted for publication by Karger Publishers are subject to copy editing. Changes introduced by the copy editor and/or questions will be marked in the manuscript and should be checked against the proofs (the edited manuscript will be returned with the proofs)..
An e-mail containing a link to download the proofs will be sent to the corresponding author. Proofs should be returned within 48 hours. Alterations made in proofs, other than the correction of introduced errors, are charged to the author and may require editorial approval.
Digital Object Identifier (DOI)
A DOI number will be available as a unique identifier on the title page of each article. DOIs are useful for identifying and citing articles published online without volume or issue information (information can be found at www.doi.org).
High quality reprints can be purchased for all papers published. Order forms and a price list are sent with the proof information. Orders submitted after the issue is published are subject to considerably higher prices.